Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial

Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial

Preclinical studies and small clinical trials suggest that glucagon-like peptide 1 (GLP1) may have a positive effect on ventricular function. Liraglutide is a GLP1-analogue used in the treatment of type 2 diabetes. LIPER2 is a phase IV, randomised, double-blind, placebo-controlled, parallel-design t...

Full description

Bibliographic Details
Main Authors: Ana María Wägner, Guillermo Miranda-Calderín, Miren Arantza Ugarte-Lopetegui, Héctor Marrero-Santiago, Laura Suárez-Castellano, María del Pino Alberiche-Ruano, Nuria Castillo-García, María José López-Madrazo, Carolina Alemán, Carla Martínez-Mancebo, Laura López-Ríos, Alicia Díez del Pino, Francisco Javier Nóvoa-Mogollón
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Randomised controlled trial
Ergometry
Maximal oxygen consumption
Ventricular function
Diabetes
GLP1-agonist
Online Access:http://www.sciencedirect.com/science/article/pii/S245186541630014X

Internet

http://www.sciencedirect.com/science/article/pii/S245186541630014X

Similar Items